The VeriStrat® Test
- Multivariate test that identifies the chronic elevation of acute phase reactants
- Profiles both acute and chronic inflammatory states, which are known to be associated with aggressive cancer
- Impacts treatment strategy and facilitates disease state monitoring
- Clinically available and reimbursed for over 210 million lives in the U.S.